Binxian Wei's most recent trade in Palisade Bio Inc was a trade of 592,300 Common Stock done . Disclosure was reported to the exchange on June 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palisade Bio Inc | Binxian Wei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 592,300 | 593,155 | - | - | Common Stock | |
| Palisade Bio Inc | Binxian Wei | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 20,200 | 40,400 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | Binxian Wei | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 20,200 | 613,355 | - | - | Common Stock | |
| Palisade Bio Inc | Binxian Wei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2025 | 510,700 | 510,700 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | Binxian Wei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2025 | 60,600 | 60,600 | - | - | Restricted Stock Units | |
| Palisade Bio Inc | Binxian Wei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 18,800 | 18,800 | - | - | Phantom Units | |
| Palisade Bio Inc | Binxian Wei | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2024 | 388 | 855 | - | 0 | Comon Stock, par value $0.01 | |
| Palisade Bio Inc | Binxian Wei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2024 | 2,100 | 2,100 | - | - | Common Stock Options | |
| Palisade Bio Inc | Binxian Wei | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2024 | 465 | 467 | - | 0 | Comon Stock, par value $0.01 | |
| Palisade Bio Inc | Binxian Wei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2023 | 9,580 | 9,580 | - | - | Common Stock Options | |
| Palisade Bio Inc | Binxian Wei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2023 | 6,980 | 6,980 | - | - | Restricted Stock Units |